EFFICACY OF SUBSEQUENT CHEMOTHERAPY FOLLOWED BY PARP INHIBITOR MAINTENANCE IN PATIENTS WITH ADVANCED OVARIAN CANCER IN THE PHASE III PAOLA-1/ENGOT-OV25 TRIAL

被引：2

作者：

Marth, Christian ^{[1
,2
]}

Mouret-Reynier, Marie-Ange ^{[3
,4
]}

Lorusso, Domenica ^{[5
,6
,7
]}

Cropet, Claire ^{[8
,9
]}

Harter, Philipp ^{[10
,11
]}

Guerra, Eva ^{[12
,13
]}

Matsumoto, Takashi ^{[14
,15
]}

Vergote, Ignace ^{[16
,17
]}

Colombo, Nicoletta ^{[18
,19
,20
]}

Maenpaa, Johanna ^{[21
,22
]}

Lebreton, Coriolan ^{[23
,24
]}

De Gregorio, Nikolaus ^{[25
,26
,27
,28
]}

Mosconi, Anna Maria ^{[29
,30
]}

Rubio, Maria Jesus ^{[31
,32
]}

Bourgeois, Hugues ^{[33
,34
]}

Fasching, Peter A. ^{[35
,36
]}

Hardy-Bessard, Anne-Claire ^{[37
,38
]}

Denschlag, Dominik ^{[39
,40
]}

Pujade-Lauraine, Eric ^{[41
,42
]}

Ray-Coquard, Isabelle ^{[8
,9
]}

机构：

[1] Med Univ Innsbruck, Dept Obstet & Gynaecol, Innsbruck, Austria

[2] AGO Austria, Innsbruck, Austria

[3] Ctr Jean Perrin, Clermont Ferrand, France

[4] GINECO, Clermont Ferrand, France

[5] Ist Tumori Milano Fdn Policlin Univ A Gemelli IRC, Rome, Italy

[6] Univ Cattolica Sacro Cuore, Rome, Italy

[7] MITO, Rome, Italy

[8] Ctr Leon Berard, Lyon, France

[9] GINECO, Lyon, France

[10] Kliniken Essen Mitte, Essen, Germany

[11] AGO, Essen, Germany

[12] Hosp Univ Ramon & Cajal, Madrid, Spain

[13] GEICO, Madrid, Spain

[14] Ehime Univ Hosp, Toon, Japan

[15] GOTIC, Toon, Japan

[16] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium

[17] BGOG, Leuven, Belgium

[18] Univ Milano Bicocca, Milan, Italy

[19] European Inst Oncol IRCCS, Milan, Italy

[20] MANGO, Milan, Italy

[21] Tampere Univ Hosp, Tampere, Finland

[22] NSGO, Tampere, Finland

[23] Inst Bergonie, Bordeaux, France

[24] GINECO, Bordeaux, France

[25] Univ Klinikum Ulm, Klin Frauenheilkunde & Geburtshilfe, Ulm, Germany

[26] AGO, Ulm, Germany

[27] SLK Kliniken Heilbronn GmbH, Frauenklinik, Heilbronn, Germany

[28] AGO, Heilbronn, Germany

[29] SC Oncol Med Osp S Maria Misericordia AO Perugia, Perugia, Italy

[30] MITO, Perugia, Italy

[31] Hosp Reina Sofia, Cordoba, Spain

[32] GEICO, Cordoba, Spain

[33] Ctr Jean Bernard, Clin Victor Hugo, Le Mans, France

[34] GINECO, Le Mans, France

[35] Univ Frauen Klinik Erlangen, Erlangen, Germany

[36] AGO, Erlangen, Germany

[37] Ctr CARIO, HPCA, Plerin Sur Mer, France

[38] GINECO, Plerin Sur Mer, France

[39] Hochtaunus Kliniken, Bad Homburg, Germany

[40] AGO, Bad Homburg, Germany

[41] ARCAGY Res, Paris, France

[42] GINECO, Paris, France

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷

关键词：

D O I：

10.1136/ijgc-2023-ESGO.30

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

528

引用

页码：A21 / A21

页数：1

共 50 条

[1] Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
Harter, Philipp
Mouret-Reynier, Marie Ange
Pignata, Sandro
Cropet, Claire
Gonzalez-Martin, Antonio
Bogner, Gerhard
Fujiwara, Keiichi
Vergote, Ignace
Colombo, Nicoletta
Nottrup, Trine Jakobi
Floquet, Anne
El-Balat, Ahmed
Scambia, Giovanni
Guerra Alia, Eva Maria
Fabbro, Michel
Schmalfeldt, Barbara
Hardy-Bessard, Anne-Claire
Runnebaum, Ingo
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
GYNECOLOGIC ONCOLOGY, 2022, 164 (02) : 254 - 264
[2] Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial
Sabatier, Renaud
Rousseau, Frederique
Joly, Florence
Cropet, Claire
Montegut, Coline
Frindte, Johanna
Cinieri, Saverio
Alia, Eva M. Guerra
Polterauer, Stephan
Yoshida, Hiroyuki
Vergote, Ignace
Colombo, Nicoletta
Hietanen, Sakari
Largillier, Remi
Canzler, Ulrich
Gratet, Alain
Marme, Frederik
Favier, Laure
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
EUROPEAN JOURNAL OF CANCER, 2023, 181 : 42 - 52
[3] Efficacy of maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced ovarian cancer according to BRCA mutation genotype in the phase III PAOLA-1/ENGOT-ov25 trial.
Labidi-Galy, Sana Intidhar
Rodrigues, Manuel
Sandoval, Jose L.
Kurtz, Jean Emmanuel
Heitz, Florian
Mosconi, Anna Maria
Romero, Ignacio
Berger, Regina
Nagao, Shoji
Vergote, Ignace
Parma, Gabriella
Nottrup, Trine Jakobi
Rouleau, Etienne
Garnier, Georges
El-Balat, Ahmed
Zamagni, Claudio
Martin-Lorente, Cristina
Pujade-Lauraine, Eric
Fievet, Alice
Ray-Coquard, Isabelle Laure
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[4] Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance
Harter, Philipp
Mouret-Reynier, Marie-Ange
Lorusso, Domenica
Cropet, Claire
Guerra, Eva M.
Wolfrum-Ristau, Pia
Matsumoto, Takashi
Vergote, Ignace
Colombo, Nicoletta
Maenpaa, Johanna Unelma
Lebreton, Coriolan
de Gregorio, Nikolaus
Mosconi, Anna Maria
Rubio-Perez, Maria Jesus
Bourgeois, Hugues
Fasching, Peter A.
Hardy-Bessard, Anne-Claire
Denschlag, Dominik
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle Laure
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[5] PHASE III PAOLA-1/ENGOT-OV25 TRIAL: OLAPARIB PLUS BEVACIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH NEWLY DIAGNOSED, ADVANCED OVARIAN CANCER TREATED WITH PLATINUM-BASED CHEMOTHERAPY PLUS BEVACIZUMAB
Harter, P.
Mouret-Reynier, M. A.
Pignata, S.
Cropet, C.
Gonzalez-Martin, A.
Bogner, G.
Fujiwara, K.
Vergote, I.
Colombo, N.
Maenpaa, J.
Floquet, A.
El-Balat, A.
Lorusso, D.
Guerra Alia, E. M.
Fabbro, M.
Schmalfeldt, B.
Blessard, A. C. Hardy
Runnebaum, I.
Pujade-Lauraine, E.
Ray-Coquard, I.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A10 - A11
[6] Phase III PAOLA-1/ENGOT-ov25 trial: olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed advanced ovarian cancer treated with platinum-based chemotherapy plus bevacizumab
Harter, Philipp
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (04) : 451 - 452
[7] Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
Fujiwara, Keiichi
Fujiwara, Hiroyuki
Yoshida, Hiroyuki
Satoh, Toyomi
Yonemori, Kan
Nagao, Shoji
Matsumoto, Takashi
Kobayashi, Hiroaki
Bourgeois, Hughes
Harter, Philipp
Mosconi, Anna Maria
Palacio Vazquez, Isabel
Reinthaller, Alexander
Fujita, Tomoko
Rowe, Philip
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (05)
[8] Time without symptoms or toxicity (TWiST) in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib or placebo plus bevacizumab: Analysis of PAOLA-1/ENGOT-ov25 phase III trial.
Joly, Florence
Chabaud, Sylvie
Cropet, Claire
Anota, Amelie
Demarchi, Martin
Atasevan, Beyhan
Pisano, Carmen
Lainez, Nuria
Tsibulak, Irina
Yonemori, Kan
Vergote, Ignace
Lapresa, Maria
Mirza, Mansoor Raza
Guillemet, Cecile
Burges, Alexander
Scambia, Giovanni
Izquierdo, Eugenia Ortega
Pujade-Lauraine, Eric
Kurtz, Jean Emmanuel
Ray-Coquard, Isabelle Laure
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[9] PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial
Loverix, Liselore
Vergote, Ignace
Busschaert, Pieter
Vanderstichele, Adriaan
Venken, Tom
Boeckx, Bram
Harter, Philipp
Brems, Hilde
Van Nieuwenhuysen, Els
Pignata, Sandro
Baert, Thais
Gonzalez-Martin, Antonio
Han, Sileny
Marth, Christian
Neven, Patrick
Colombo, Nicoletta
Berteloot, Patrick
Maeenpaeae, Johanna
Olbrecht, Siel
Laga, Tina
Sablon, Erwin
Ray-Coquard, Isabelle
Pujade-Lauraine, Eric
Lambrechts, Diether
Van Gorp, Toon
EUROPEAN JOURNAL OF CANCER, 2023, 188 : 131 - 139
[10] Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial
Callens, Celine
Vaur, Dominique
Soubeyran, Isabelle
Rouleau, Etienne
Just, Pierre-Alexandre
Guillerm, Erell
Golmard, Lisa
Goardon, Nicolas
Sevenet, Nicolas
Cabaret, Odile
Harter, Philipp
Gonzalez-Martin, Antonio
Fujiwara, Keiichi
Cecere, Sabrina Chiara
Colombo, Nicoletta
Marth, Christian
Vergote, Ignace
Maenpaa, Johanna
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 917 - 923

← 1 2 3 4 5 →